• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Ligand Pharmaceuticals Incorporated - Common Stock (NQ:LGND)

    302.15 -0.59 (-0.19%)
    Delayed Quote Updated: 9:36 AM EDT, Oct 2, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 5,385
    Open 307.55
    Bid (Size) 297.88 (100)
    Ask (Size) 306.43 (100)
    Prev. Close 302.74
    Today's Range 302.15 - 307.55
    52wk Range 175.56 - 326.63
    Shares Outstanding 16,676,532
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Ligand Pharmaceuticals (NASDAQ:LGND) Flashes Strong Trend and High-Growth Momentum Despite Setup Caution ↗
    Via Chartmill
    News headline image
    If You Invested $100 In Ligand Pharmaceuticals Stock 5 Years Ago, You Would Have This Much Today ↗
    Ligand Pharmaceuticals (NASDAQ:LGND) has outperformed the market over the past 5 years by 17.28% on an annualized basis producing an average annual return of 28.4%. Currently, Ligand Pharmaceuticals... 
    Via Benzinga

    Performance

    YTD
    +58.9%
    +58.9%
    1 Month
    +6.3%
    +6.3%
    3 Month
    -5.4%
    -5.4%
    6 Month
    +51.4%
    +51.4%
    1 Year
    +68.7%
    +68.7%

    More News

    Read More
    News headline image
    Ligand Pharmaceuticals Highlights XOMA-Fueled Royalty Growth, $700M in Deployable Capital ↗
    Via MarketBeat
    News headline image
    $100 Invested In Ligand Pharmaceuticals 10 Years Ago Would Be Worth This Much Today ↗
    Via Benzinga
    News headline image
    Ligand (LGND) Q2 2026 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    Ligand Pharmaceuticals (NASDAQ:LGND) Beats Q2 EPS Estimates, Shares Flat on In-Line Revenue ↗
    Via Chartmill
    News headline image
    Ligand Pharmaceuticals Q2 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    News headline image
    $100 Invested In Ligand Pharmaceuticals 15 Years Ago Would Be Worth This Much Today ↗
    Via Benzinga
    News headline image
    Ligand Completes Acquisition of XOMA Royalty, Creating a Portfolio of More than 200 Biopharmaceutical Royalty Assets
    From Ligand Pharmaceuticals
    Via GlobeNewswire
    News headline image
    XOMA Royalty Announces Closing of Its Acquisition by Ligand
    From XOMA Royalty Corporation
    Via GlobeNewswire
    Ligand Pharmaceuticals (NASDAQ:LGND) Shares Fall on Q1 Revenue and EPS Miss ↗
    Via Chartmill
    News headline image
    3 Overlooked Stocks Positioned for the Next Market Rotation ↗
    Via MarketBeat
    Topics Artificial Intelligence
    News headline image
    Ligand Pharmaceuticals Director Unloads 2,501 Shares — Should You Be Concerned? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    A Ligand Pharmaceuticals (LGND) Insider Sold 5,000 Shares for $1.1 Million ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Wealth Manager Sells $7 Million of Establishment Labs After Massive Gains. Is This Medical Device Stock a Buy? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    OneSpaWorld Posted Record Revenue for Last Quarter. Why Did a Fund Exit a $21.5 Million Stake? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Is Genpact Stock a Buy After Hedge Fund Rice Hall James Raised Its Stake by $14 Million? ↗
    Via The Motley Fool
    Topics Artificial Intelligence Economy
    News headline image
    Is WaterBridge Stock a Buy After Ranger Investment Raised Its Stake by 345,000 Shares? ↗
    Via The Motley Fool
    Topics Initial Public Offering
    News headline image
    Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    News headline image
    Ligand (LGND) Q1 2026 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Ligand Pharmaceuticals Q1 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    News headline image
    Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Financing Agreement
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    News headline image
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: XOMA Royalty Corporation (Nasdaq – XOMA), Organon & Co. (NYSE – OGN), RE/MAX Holdings, Inc. (NYSE – RMAX), Soleno Therapeutics, Inc. (Nasdaq – SLNO)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    News headline image
    Villere St Denis Liquidates $18 Million Euronet Worldwide Stake, According to Recent SEC Filing ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Villere St Denis Dumps 134,000 Tidewater (TDW) Shares Worth $9.3 Million ↗
    Via The Motley Fool
    Topics Energy Regulatory Compliance

    Frequently Asked Questions

    Is Ligand Pharmaceuticals Incorporated - Common Stock publicly traded?
    Yes, Ligand Pharmaceuticals Incorporated - Common Stock is publicly traded.
    What exchange does Ligand Pharmaceuticals Incorporated - Common Stock trade on?
    Ligand Pharmaceuticals Incorporated - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Ligand Pharmaceuticals Incorporated - Common Stock?
    The ticker symbol for Ligand Pharmaceuticals Incorporated - Common Stock is LGND on the Nasdaq Stock Market
    What is the current price of Ligand Pharmaceuticals Incorporated - Common Stock?
    The current price of Ligand Pharmaceuticals Incorporated - Common Stock is 302.15
    When was Ligand Pharmaceuticals Incorporated - Common Stock last traded?
    The last trade of Ligand Pharmaceuticals Incorporated - Common Stock was at 10/02/26 09:36 AM ET
    What is the market capitalization of Ligand Pharmaceuticals Incorporated - Common Stock?
    The market capitalization of Ligand Pharmaceuticals Incorporated - Common Stock is 5.04B
    How many shares of Ligand Pharmaceuticals Incorporated - Common Stock are outstanding?
    Ligand Pharmaceuticals Incorporated - Common Stock has 5B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.